205 related articles for article (PubMed ID: 18601597)
1. APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels.
Hubacek JA; Wang WW; Skodová Z; Adámková V; Vráblík M; Horínek A; Stulc T; Ceska R; Talmud PJ
Clin Chem Lab Med; 2008; 46(6):773-7. PubMed ID: 18601597
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the distribution of plasma HDL subclasses and the polymorphisms of APOA5 in hypertriglyceridemia.
Long S; Chen Z; Han Y; Christopher DM; Zhang C; Yang Y; Tian Y
Clin Biochem; 2013 Jun; 46(9):733-9. PubMed ID: 23499587
[TBL] [Abstract][Full Text] [Related]
3. Interaction between APOA5 -1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia.
Sousa MO; Alía P; Pintó X; Corbella E; Navarro MA
Clin Chim Acta; 2008 Sep; 395(1-2):68-71. PubMed ID: 18549811
[TBL] [Abstract][Full Text] [Related]
4. APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects.
Jang Y; Chae JS; Kim OY; Park HJ; Kim JY; Paik JK; Lee SH; Lee JH
Atherosclerosis; 2010 Aug; 211(2):512-9. PubMed ID: 20392444
[TBL] [Abstract][Full Text] [Related]
5. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.
Henneman P; Schaap FG; Havekes LM; Rensen PC; Frants RR; van Tol A; Hattori H; Smelt AH; van Dijk KW
Atherosclerosis; 2007 Jul; 193(1):129-34. PubMed ID: 16777114
[TBL] [Abstract][Full Text] [Related]
6. Resequencing the apolipoprotein A5 (APOA5) gene in patients with various forms of hypertriglyceridemia.
Evans D; Aberle J; Beil FU
Atherosclerosis; 2011 Dec; 219(2):715-20. PubMed ID: 21993410
[TBL] [Abstract][Full Text] [Related]
7. Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia.
Pisciotta L; Fresa R; Bellocchio A; Guido V; Priore Oliva C; Calandra S; Bertolini S
Clin Chim Acta; 2011 Nov; 412(23-24):2194-8. PubMed ID: 21846464
[TBL] [Abstract][Full Text] [Related]
8. Association of APOA5 c.553G>T polymorphism with type 2 diabetes mellitus in a Chinese population.
Zhai G; Wen P; Guo L; Chen L
Clin Chem Lab Med; 2006; 44(11):1313-6. PubMed ID: 17087641
[TBL] [Abstract][Full Text] [Related]
9. DNA polymorphisms and haplotypes of apolipoprotein A5's attribution to the plasma triglyceride levels in Koreans.
Choi JR; Nam CM; Kang DR; Eom SM; Lee HJ; Park CM; Im JW; Jang Y
Yonsei Med J; 2007 Aug; 48(4):609-18. PubMed ID: 17722232
[TBL] [Abstract][Full Text] [Related]
10. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
[TBL] [Abstract][Full Text] [Related]
11. Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study.
Ariza MJ; Sánchez-Chaparro MA; Barón FJ; Hornos AM; Calvo-Bonacho E; Rioja J; Valdivielso P; Gelpi JA; González-Santos P
BMC Med Genet; 2010 Apr; 11():66. PubMed ID: 20429872
[TBL] [Abstract][Full Text] [Related]
12. Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene.
Priore Oliva C; Carubbi F; Schaap FG; Bertolini S; Calandra S
J Intern Med; 2008 Apr; 263(4):450-8. PubMed ID: 18324930
[TBL] [Abstract][Full Text] [Related]
13. The c.553G>T Genetic Variant of the APOA5 Gene and Altered Triglyceride Levels in the Asian Population: A Meta-Analysis of Case-Control Studies.
He H; Lei L; Chen E; Dong J; Zhang K; Yang J
Genet Test Mol Biomarkers; 2016 Dec; 20(12):758-765. PubMed ID: 27813673
[TBL] [Abstract][Full Text] [Related]
14. Overweight modulates APOE and APOA5 alleles on the risk of severe hypertriglyceridemia.
Lee MJ; Chien KL; Chen MF; Stephenson DA; Su TC
Clin Chim Acta; 2013 Feb; 416():31-5. PubMed ID: 23178747
[TBL] [Abstract][Full Text] [Related]
15. Changes of plasma lipids during weight reduction in females depends on APOA5 variants.
Suchanek P; Lorenzova A; Poledne R; Hubacek JA
Ann Nutr Metab; 2008; 53(2):104-8. PubMed ID: 18946207
[TBL] [Abstract][Full Text] [Related]
16. Frequency of rare mutations and common genetic variations in severe hypertriglyceridemia in the general population of Spain.
Lamiquiz-Moneo I; Blanco-Torrecilla C; Bea AM; Mateo-Gallego R; Pérez-Calahorra S; Baila-Rueda L; Cenarro A; Civeira F; de Castro-Orós I
Lipids Health Dis; 2016 Apr; 15():82. PubMed ID: 27108409
[TBL] [Abstract][Full Text] [Related]
17. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.
Dallongeville J; Cottel D; Montaye M; Codron V; Amouyel P; Helbecque N
Int J Cardiol; 2006 Jan; 106(2):152-6. PubMed ID: 16321685
[TBL] [Abstract][Full Text] [Related]
18. Stepwise positive association between APOA5 minor allele frequencies and increasing plasma triglyceride quartiles in random patients with hypertriglyceridemia of unclarified origin.
Hadarits F; Kisfali P; Mohás M; Maász A; Sümegi K; Szabó M; Hetyésy K; Valasek A; Janicsek I; Wittmann I; Melegh B
Pathol Oncol Res; 2011 Mar; 17(1):39-44. PubMed ID: 20490738
[TBL] [Abstract][Full Text] [Related]
19. The APOA5-1131 T>C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes.
Cabré A; Lázaro I; Girona J; Manzanares JM; Marimón F; Plana N; Guardiola M; Heras M; Masana L
Nutr Metab Cardiovasc Dis; 2010 May; 20(4):243-8. PubMed ID: 19765959
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein A5 and hypertriglyceridemia in Prague hypertriglyceridemic rats.
Kadlecová M; Hojná S; Bohuslavová R; Hubácek JA; Zicha J; Kunes J
Physiol Res; 2006; 55(4):373-379. PubMed ID: 16238453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
